Study title * Safety and Efficacy Evaluation of UltheraTM in Treatment of Baggy Eyelid Study design * single arm and Investigator Initiative pilot study
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
7
UltheraTM 100 shots (infraorbital region 30shots, lateral orbital region 40shots, upper eyelid 30 shots) on the Rt, and Lt periorbital area, respectively using 1.5mm and 3.0mm probe
Seoul National Univ. Bundang Hospital, Gumi-dong, Bundang-gu
Seongnam-si, Gyeonggi-do, South Korea
The distance from the inferior orbital rim to the skin
Difference between the distance ( from the inferior orbital rim to the skin) measured by orbital CT at Screening and 12weeks after UltheraTM treatment
Time frame: Change from Screening in distance at 12weeks after Ulthera treatment
The distance from the most protrusive baggy eyelid to the orbital septum
The distance(mm),from the most protrusive baggy eyelid to the orbital septum will be measured by a plastic surgeon with orbital CT films. Each participant will do Orbital CT scan 2 times, at screening and 12weeks after treatment
Time frame: Change from Screening in distance at 12weeks after UltheraTM treatment
Subject Satisfaction for baggy lower eyelid
5-point scale for Subject Satisfaction in baggy lower eyelid. The subject satisfaction is calculated as a score between 0 and 4( 0= very poor, 4= very good).
Time frame: Change from Screening in satisfaction at 4 weeks and 12weeks
Improvement of baggy lower eyelid
Improvement of baggy lower eyelid will be assessed by Two plastic surgeons. Both assessors will evaluate Improvement of baggy lower eyelid including skin laxity and orbital fat prolapse using 5-point scale. 0= no involvement 1. mild 2. moderate 3. marked 4. severe
Time frame: Change from Screening in baggy lower eyelid at 12weeks after UltheraTM treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.